NYSE:IVC Invacare (IVC) Stock Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free IVC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.35▼$0.7452-Week Range N/AVolume33,301 shsAverage Volume240,305 shsMarket Capitalization$20.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invacare alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Invacare Stock (NYSE:IVC)Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.Read More Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. IVC Stock News HeadlinesFebruary 27, 2024 | finance.yahoo.comNorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of ManagersFebruary 14, 2024 | sports.yahoo.comBuckeye Trail coasts past Newcomerstown for key IVC winMay 5, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?November 14, 2023 | finanznachrichten.deINVO Bioscience, Inc.: INVO Reports Record Third Quarter 2023 Financial ResultsOctober 14, 2023 | finance.yahoo.comIL&FS Investment Managers Limited (IVC.NS)August 22, 2023 | thestreet.comStocks Rally After CPI Comes Out in Line With ExpectationsJune 26, 2023 | finance.yahoo.comInvacare Holdings Corporation Names Kai Zhu Senior Vice President and Chief Financial OfficerMay 15, 2023 | finance.yahoo.comInvacare Reports Results for First Quarter 2023May 5, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?May 10, 2023 | marketwatch.comInvacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its TransformationApril 17, 2023 | finance.yahoo.comINVO Reports Fourth Quarter and Full Year 2022 Financial ResultsFebruary 1, 2023 | finance.yahoo.comInvacare files for bankruptcyFebruary 1, 2023 | finance.yahoo.comInvacare Files For Chapter 11, But Expects To Continue Focusing On Home-Care ProductsFebruary 1, 2023 | finance.yahoo.comInvacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International OperationsFebruary 1, 2023 | finance.yahoo.comInvacare files for bankruptcy, but expects to keep making and delivering home-care productsFebruary 1, 2023 | investorplace.comWhy Is Invacare (IVC) Stock Down 20% Today?December 27, 2022 | finance.yahoo.comInvacare draws more on term loan from hedge fund managerDecember 27, 2022 | finance.yahoo.comInvacare Corporation Announces Additional Draw of Term LoansNovember 23, 2022 | 247wallst.comAzurite Trims Invacare Stake after Inadvertently Passing 10% Ownership TriggerNovember 22, 2022 | finance.yahoo.comInvacare picks Geoff Purtill as permanent president, CEONovember 21, 2022 | finance.yahoo.comInvacare Appoints Geoff Purtill President and Chief Executive OfficerNovember 14, 2022 | finance.yahoo.comThe Consensus EPS Estimates For Invacare Corporation (NYSE:IVC) Just Fell DramaticallyNovember 10, 2022 | finance.yahoo.comInvacare Third Quarter 2022 Earnings: Misses ExpectationsNovember 7, 2022 | finance.yahoo.comInvacare Reports Results for Third Quarter 2022October 20, 2022 | businesswire.comInvacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results - Business WireOctober 20, 2022 | finance.yahoo.comInvacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial ResultsOctober 15, 2022 | globenewswire.comWheelchairs & Mobility Aids Market Research Report by Product, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - GlobeNewswireSee More Headlines Receive IVC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today5/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment Current SymbolNYSE:IVC CUSIP46120310 CIK742112 Webwww.invacare.com Phone(440) 329-6000Fax877-619-7996Employees3,000Year Founded1885Profitability EPS (Most Recent Fiscal Year)($2.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-45,560,000.00 Net Margins-9.99% Pretax Margin-9.38% Return on Equity-37.76% Return on Assets-7.18% Debt Debt-to-Equity Ratio4.82 Current Ratio1.32 Quick Ratio0.78 Sales & Book Value Annual Sales$872.46 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.77 Book Value$5.54 per share Price / BookN/AMiscellaneous Outstanding Shares37,760,000Free Float35,153,000Market Cap$20.01 million OptionableOptionable Beta0.38 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesGeoffrey P. PurtillPresident, Chief Executive Officer & DirectorKathleen Patricia LeneghanSenior VP, Chief Financial & Accounting OfficerAngie GoodwinSVP, Chief Technology & Information OfficerJoost BeltmanSenior VP & General Manager-North AmericaAnthony C. LaPlacaSecretary, Chief Administrative Officer & SVPKey CompetitorsNutribandNASDAQ:NTRBHeart Test LaboratoriesNASDAQ:HSCSPredictive OncologyNASDAQ:POAIReWalk RoboticsNASDAQ:LFWDMilestone ScientificNYSE:MLSSView All Competitors IVC Stock Analysis - Frequently Asked Questions How were Invacare's earnings last quarter? Invacare Co. (NYSE:IVC) announced its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 37.76% and a negative net margin of 9.99%. During the same quarter last year, the company posted ($0.10) earnings per share. What is Matthew E. Monaghan's approval rating as Invacare's CEO? 51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Invacare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO). This page (NYSE:IVC) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsBiden Nomination CANCELED?The Freeport SocietyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invacare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
